Profiel
Noel L.
Goddard was the founder of Goddard Labs, Inc. (2012) as Chief Executive Officer.
Dr. Goddard is the founder of Qunnect, Inc. as Chief Executive Officer since 2020.
Former positions include Director at Biolabs, Inc. (2017-2018), Director at Hashlynx, Inc. (2021-2022), Independent Director at Monogram Technologies, Inc., Advisor at The Catalytic Impact Foundation, Inc. (2019-2021), Advisor at M Corp.
(2019-2021), Chief Technology Officer at Symbiotic Health, Inc. (2015-2018), and Portfolio Manager at Accelerate Long Island (Venture Capital) (2020-2022).
Education includes a doctorate from The Rockefeller University (2004), an undergraduate degree from New York University (1996), and a graduate degree from New York University (1998).
Actieve functies van Noel Goddard
| Bedrijven | Functie | Begin |
|---|---|---|
Qunnect, Inc.
Qunnect, Inc. Computer Processing HardwareElectronic Technology Develops quantum hardware parts | Algemeen Directeur | 01-05-2020 |
Eerdere bekende functies van Noel Goddard
| Bedrijven | Functie | Einde |
|---|---|---|
Hashlynx, Inc.
Hashlynx, Inc. Information Technology ServicesTechnology Services Operates as a block chain technology to trade and settle syndicated loan markets | Directeur/Bestuurslid | 31-01-2022 |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island (Venture Capital) invests in companies located in the United States. The firm targets companies operating across a broad of sectors and industries. It provides financing for seed capital requirements. | Private Equity Investor | 01-01-2022 |
M Corp.
M Corp. Miscellaneous Commercial ServicesCommercial Services Provides information technology solutions and consulting services | Consultant / Adviseur | 31-12-2021 |
The Catalytic Impact Foundation, Inc.
The Catalytic Impact Foundation, Inc. The Catalytic Impact Foundation, Inc. is a nonprofit venture philanthropy organization that accelerates innovation in life sciences and healthcare by investing philanthropic capital with venture discipline into early-stage companies addressing critical unmet medical needs. The private company is located in the US. The foundation bridges the funding gap between early research and commercialization to bring health technologies to patients, focusing on underfunded areas such as women’s health, children’s health, brain and mental health, rare diseases, health equity, and aging. It prioritizes scalable, accessible solutions for conditions that disproportionately affect or are poorly addressed in these populations and supports women-led companies through its women leaders in health innovation initiative. The foundation operates with a regenerative philanthropy model, using donated capital to make equity investments in promising life science companies and recycling returns to sustain and scale impact. Its portfolio includes companies developing diagnostics, drug delivery systems, and medical devices, and it also offers fiscal sponsorship to mission-aligned projects lacking nonprofit status. | Consultant / Adviseur | 31-01-2021 |
Symbiotic Health, Inc.
Symbiotic Health, Inc. BiotechnologyHealth Technology Develops probiotic microbes that supports healthy aging | Hoofd Techniek/Wetenschap/O&O | 30-04-2018 |
Opleiding van Noel Goddard
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Biolabs, Inc.
Biolabs, Inc. Medical/Nursing ServicesHealth Services Operates a healthcare laboratory | Health Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
M Corp.
M Corp. Miscellaneous Commercial ServicesCommercial Services Provides information technology solutions and consulting services | Commercial Services |
Symbiotic Health, Inc.
Symbiotic Health, Inc. BiotechnologyHealth Technology Develops probiotic microbes that supports healthy aging | Health Technology |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island (Venture Capital) invests in companies located in the United States. The firm targets companies operating across a broad of sectors and industries. It provides financing for seed capital requirements. | Finance |
Monogram Orthopaedics, Inc.
Monogram Orthopaedics, Inc. Medical SpecialtiesHealth Technology Develops robotics orthopedic devices | Health Technology |
Hashlynx, Inc.
Hashlynx, Inc. Information Technology ServicesTechnology Services Operates as a block chain technology to trade and settle syndicated loan markets | Technology Services |
Goddard Labs, Inc.
Goddard Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology research and development company | Commercial Services |
Qunnect, Inc.
Qunnect, Inc. Computer Processing HardwareElectronic Technology Develops quantum hardware parts | Electronic Technology |
The Catalytic Impact Foundation, Inc.
The Catalytic Impact Foundation, Inc. The Catalytic Impact Foundation, Inc. is a nonprofit venture philanthropy organization that accelerates innovation in life sciences and healthcare by investing philanthropic capital with venture discipline into early-stage companies addressing critical unmet medical needs. The private company is located in the US. The foundation bridges the funding gap between early research and commercialization to bring health technologies to patients, focusing on underfunded areas such as women’s health, children’s health, brain and mental health, rare diseases, health equity, and aging. It prioritizes scalable, accessible solutions for conditions that disproportionately affect or are poorly addressed in these populations and supports women-led companies through its women leaders in health innovation initiative. The foundation operates with a regenerative philanthropy model, using donated capital to make equity investments in promising life science companies and recycling returns to sustain and scale impact. Its portfolio includes companies developing diagnostics, drug delivery systems, and medical devices, and it also offers fiscal sponsorship to mission-aligned projects lacking nonprofit status. |
















